HOME >> BIOLOGY >> NEWS
UT Southwestern joins national clinical trial to uncover long-term effects of West Nile virus

DALLAS May 17, 2007 UT Southwestern Medical Center has joined a national clinical trial to identify the long-term health effects of West Nile virus infection and to learn more about the disease's progression, symptoms and mortality.

In the trial, initiated by the National Institutes of Health Clinical Center, researchers at 13 U.S. sites are observing the natural course of the virus over a year in people who have either a fever or neurological diseases due to West Nile infection.

Study participants undergo brain imaging and blood, neurological and cognitive testing.

"Little is known about the long-term effects of infection, so information gathered in this trial could help bridge the gaps in current knowledge of West Nile and aid in the design of better treatments," said Dr. Roger Bedimo, assistant professor of internal medicine at UT Southwestern and chief of infectious disease at the Veterans Administration North Texas Health Care System. Dr. Bedimo is principal investigator of the trial site at UT Southwestern.

West Nile virus, transmitted by mosquito bite, arrived in the U.S. in 1999 and has become a seasonal illness that flares up between May and October. The young, the elderly and people with weak immune systems are most at risk.

About 7 percent of all U.S. cases of West Nile appear in Texas each year. Last year, 23 percent or 81 cases of Texas' 354 verified human infections were in Dallas County.

West Nile virus infection has three main forms. Most people have no symptoms and their immune system clears out the virus. One in 5 people develops a fever West Nile Fever that causes mild flu-like symptoms. One in 150 develops serious neurological illness, such as severe headache, muscle weakness, cognitive impairment, coma, seizures and encephalitis and myelitis.

Since there is no vaccine, doctors can only treat symptoms of the disease.

Several researchers at UT Southwestern
'"/>

Contact: Cliff Despres
Cliff.Despres@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
17-May-2007


Page: 1 2

Related biology news :

1. UT Southwestern leaders to receive national award for medical research accomplishments
2. UT Southwestern scientist receives NIH Directors Pioneer Award
3. UT Southwestern scientist named Keck Foundation Distinguished Young Scholar in Medical Research
4. UT Southwestern researchers find gene mutation that leads to broken hearts
5. Plague agent helps UT Southwestern researchers find novel signaling system in cells
6. One of the nations first 7-Tesla magnetic resonance imaging devices for human studies planned at UT Southwestern Medical Center
7. DNA end caps may lead to cancer treatments, UT Southwestern researchers report
8. UT Southwestern scientist honored among best in Texas research
9. UT Southwestern scientist receives international award for pediatric research
10. UT Southwestern physician-researcher wins international award for lipid research
11. UT Southwestern scientist elected to National Academy of Sciences Institute of Medicine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2020)... ... April 20, 2020 , ... RCH Solutions (RCH ), a ... sizes, announces the hiring of Michael Wlodarczyk as Director of Sales and Business Development. ... and grow the company’s already strong presence across the Northeast. , “We continue to ...
(Date:4/22/2020)... ... April 21, 2020 , ... ... and innovation in technology and compliance, announces a new managed service to improve ... of alliances – Box, ComplianceQuest, and USDM Life Sciences (USDM) – Unify Compliance ...
(Date:4/18/2020)... ... 16, 2020 , ... SIRION Biotech GmbH , a world leader in ... present a company update on its work expediting gene therapy research and advancing drug ... 22 and 23. Dieter Lingelbach, the Company’s Chief Operating Officer, will also provide an ...
Breaking Biology News(10 mins):
(Date:5/15/2020)... ... May 14, 2020 , ... ... cell (hMSC) working cell banks and hMSC bioprocess systems, today announced the ... collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed ...
(Date:5/14/2020)... ... May 12, 2020 , ... ... is bringing together thousands of industry leaders, clinicians, research scientists, medical professionals and ... speakers, Carl June, MD, Director of the Center for Cellular Immunotherapies at the ...
(Date:5/5/2020)... ... May 05, 2020 , ... ProductLife Group has ... Xavier Duburcq joins the group after 13 years at Altran, where he was Group ... PhD in Immunology and being a Pharmacist, Xavier was involved in his early career ...
(Date:4/22/2020)... CAMBRIDGE, Mass. (PRWEB) , ... April 20, 2020 ... ... with US offices in Cambridge, MA, announced today that Omixon’s founder and chairman ... early commercialisation of Omixon’s flagship product Holotype HLA since 2014 before stepping into ...
Breaking Biology Technology:
Cached News: